✨
AI Summary
- Roundtable discussion featuring Steven Austad, Richard Miller, and Matt Kaeberlein explores the rapidly evolving field of geroscience and the healthspan versus lifespan relationship
- Evaluation of geroprotective interventions including rapamycin and senolytics is examined, with exploration of GLP-1 receptor agonists' potential longevity benefits and epigenetic aging mechanisms
- Major challenges in longevity research funding and public acceptance are tackled, alongside discussion of how geroprotective interventions might be tested in human populations
Guests on This Episode
MK
Matt Kaeberlein
6 podcast appearances
RM
Richard Miller
2 podcast appearances
SA
Steven Austad
1 podcast appearance